A novel therapy could help patients with active Crohn’s disease

Dr Jahnsen's study aims to improve symptoms experienced by patients with Crohn’s disease, such as abdominal pain.

Professor Jørgen Jahnsen and PhD student Kristian Espeland of Akershus University Hospital and University of Oslo are responsible for a new clinical trial which aims to improve symptoms and control the inflammation of Crohn’s disease using Gliolan medication in combination with blue-light photopheresis. This approach will selectively cause the death of pro-inflammatory cells which contribute to the inflammatory bowel disease, […]

Read More… from A novel therapy could help patients with active Crohn’s disease